BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18618632)

  • 1. [Benign prostatic hypertrophy and the benign prostatic syndrome].
    Orth M
    Pharm Unserer Zeit; 2008; 37(4):315-21. PubMed ID: 18618632
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus conference about imaging of Benign Prostatic Hypertrophy.
    Gozzi G; Conti G; Peroni R; Spatafora S; Pavlica P; Cammarota T; Bertolotto M
    Radiol Med; 2005 Sep; 110(3):179-89. PubMed ID: 16200040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endourological treatment of benign prostatic hypertrophy. Preliminary report].
    Rodríquez Duarte C
    Arch Esp Urol; 1991 Apr; 44(3):283-5. PubMed ID: 1714266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benign prostatic hyperplasia: background and diagnosis].
    Gratzke C; Schlenker B; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):25-8. PubMed ID: 17912862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    McNaughton-Collins M; Barry MJ
    Am J Med; 2005 Dec; 118(12):1331-9. PubMed ID: 16378773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder.
    Mitterberger M; Pallwein L; Gradl J; Frauscher F; Neuwirt H; Leunhartsberger N; Strasser H; Bartsch G; Pinggera GM
    BJU Int; 2007 Apr; 99(4):831-5. PubMed ID: 17244278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and medical management of benign prostatic hyperplasia.
    Beckman TJ; Mynderse LA
    Mayo Clin Proc; 2005 Oct; 80(10):1356-62. PubMed ID: 16212149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing benign prostatic hyperplasia versus prostate cancer.
    Denis LJ
    Br J Urol; 1995 Jul; 76 Suppl 1():17-23. PubMed ID: 7544211
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urology imaging: contribution of imaging in benign prostatic hypertrophy].
    Descotes JL; Hubert J
    Prog Urol; 2003 Nov; 13(5):1049-61. PubMed ID: 14763396
    [No Abstract]   [Full Text] [Related]  

  • 11. Benign prostatic hyperplasia. New concepts in the 1990s.
    Moul JW
    Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the diagnosis of benign prostatic hyperplasia. A critical review.
    el Din KE; Debruyne FM; de la Rosette JJ
    Eur Urol; 1997; 31(3):257-62. PubMed ID: 9129913
    [No Abstract]   [Full Text] [Related]  

  • 14. [The transurethral microwave thermotherapy of benign prostatic hyperplasia].
    Prokhorov AV; Karpov VK; Sivkov AV; Apolikhin OI; Ignashin NS; Churakov BI
    Urol Nefrol (Mosk); 1997; (4):22-5. PubMed ID: 9381615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of benign prostatic hypertrophy in the community.
    Garraway WM; Collins GN; Lee RJ
    Lancet; 1991 Aug; 338(8765):469-71. PubMed ID: 1714529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia.
    Bruskewitz R
    J Urol; 1997 Jul; 158(1):100-1. PubMed ID: 9186332
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of benign prostatic hyperplasia by family physicians.
    Toguri A; Barkin J
    Can J Urol; 2010 Feb; 17 Suppl 1():26-34. PubMed ID: 20170598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of benign prostatic hypertrophy].
    Romics I
    Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.